Concepedia

Trial Endpoint Selection

Trial Endpoint Selection is a methodological decision process in clinical vaccine trials that identifies and defines specific, measurable outcomes used to evaluate the efficacy and safety of a vaccine candidate, distinguishing it from other trial design elements by focusing on the primary and secondary variables that determine trial success.

53

Publications

3K

Citations

324

Authors

210

Institutions

Publications per year

2017–2026

17

Parents

Publications

53

Proposal for Standardized Definitions for Efficacy End Points in Adjuvant Breast Cancer Trials: The STEEP System

Clifford A. Hudis, William E. Barlow, Joseph P. Costantino et al. · Journal of Clinical Oncology · 2007 · 885 citations · Full text

, , +17

The Clinical Viewpoint: Definitions, Limitations of RECIST, Practical Considerations of Measurement

Liza C. Villaruz, Mark A. Socinski · Clinical Cancer Research · 2013 · 161 citations · Full text

, , +16

A methodologic framework for developing and selecting endpoints in clinical trials.

Peter Tugwell, Claire Bombardier · PubMed · 1983 · 138 citations

, , +11

Key Issues in End Point Selection for Heart Failure Trials: Composite End Points

James D. Neaton, Gerry Gray, Bram D. Zuckerman et al. · Journal of Cardiac Failure · 2005 · 129 citations · Full text

, , +14

Efficacy endpoint selection and multiplicity adjustment methods in clinical trials with inherent multiple endpoint issues

Abdul J. Sankoh, Ralph B. D’Agostino, Mohammad F. Huque · Statistics in Medicine · 2003 · 110 citations

, , +16

1–5 of 53

Authors

324

  1. AL
    Alexandre Loupy

    Inserm, France

    3 publications · 62 citations

    3

    h-index

  2. IO
    Inish O’Doherty

    Critical Path Institute, United States

    3 publications · 62 citations

    3

    h-index

  3. RB
    Roslyn B. Mannon

    University of Alabama at Birmingham, United States

    3 publications · 62 citations

    3

    h-index

  4. TN
    Timothy N. Welsh

    University of Toronto, Canada

    2 publications · 55 citations

    2

    h-index

  5. AK
    Amanda Klein

    Critical Path Institute, United States

    2 publications · 41 citations

    2

    h-index

1–5 of 324

Institutions

210

  1. Emory University

    Atlanta, United States

    4 h-index

    4 publications

    121 citations

  2. University of California, San Francisco

    San Francisco, United States

    3 h-index

    14 publications

    428 citations

  3. Harvard University

    Cambridge, United States

    3 h-index

    3 publications

    114 citations

  4. Methodist Hospital

    Sacramento, United States

    3 h-index

    3 publications

    62 citations

  5. Critical Path Institute

    Tucson, United States

    3 h-index

    17 publications

    350 citations

  6. Cancer Research And Biostatistics

    Seattle, United States

    3 h-index

    14 publications

    9.1K citations

  7. United States Food and Drug Administration

    Silver Spring, United States

    3 h-index

    9 publications

    411 citations

  8. Tufts Medical Center

    Boston, United States

    3 h-index

    3 publications

    191 citations

1–8 of 210

Venues

  1. PubMed

    Repository · 5 publications · 228 citations

    4

    h-index

  2. Annals of Oncology

    2 publications · 129 citations

    2

    h-index

  3. Journal of Clinical Epidemiology

    2 publications · 21 citations

    2

    h-index

  4. Statistics in Medicine

    2 publications · 182 citations

    2

    h-index

  5. The Oncologist

    2 publications · 83 citations

    2

    h-index

1–5